New Orleans, June 24, 2025 – The 2025 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI 2025) successfully concluded today in New Orleans, USA. As a premier global gathering in the field, SNMMI consistently brings together cutting-edge scientific research and technological advancements....
Dr. Michael Nader, head of the Radiopharmacy Department at University Hospital Essen, is widely recognized for his extensive expertise in the development, production, and clinical application of radiopharmaceuticals. Dr. Fadi Zarrad also plays a pivotal role in the department, making significant contributions to advancing radiopharmaceutical research and operations.Accompanied by Huayi team, Dr. Nader and Dr. Zarrad toured Huayi’s radiopharmaceutical R&D center, GMP-compliant production facilities, and quality control laboratories, gaining a comprehensive understanding of Huayi’s capabilities in the full-cycle development and standardized production of radiopharmaceuticals. Both experts were highly impressed by Huayi’s technological strength and rapid progress in the field....
From May 11th to 15th, 2025, the renowned iSRS 2025 was grandly held in Gold Coast, Australia. Jiangsu Huayi Technology Co., Ltd. (hereinafter referred to as “Huayi Technology”) was honored to participate in this momentous event, gathering together with experts and leaders in the international field of radiation research to jointly explore the latest frontiers of radiation research....
Huayi Isotopes, a subsidiary of Huayi Technology Co., Ltd., has received a Drug Master File (DMF) acceptance letter from the U.S. Food and Drug Administration (FDA) for its DOTATATE ACETATE (DMF No. 041558), a peptide-based precursor for radiopharmaceuticals. ...
Huayi Pharmaceutical (Guangdong) Co., Ltd. successfully obtained the “Radioactive Pharmaceutical Production License” issued by the National Medical Products Administration. ...
We proudly announces a significant milestone with the successful acquisition of Drug Master File (DMF) registration for the PSMA-11 precursor. This achievement underscores Huayi's unwavering commitment to upholding the highest standards in the development and production of radiopharmaceuticals....
The 63rd Annual Meeting of the Japanese Society of Nuclear Medicine (JSNM) and the 43rd Annual Meeting of the Japanese Society of Nuclear Medicine Technology (JSNMT) took place in Osaka from November 16th to 18th, attracting experts from around the world. ...
Jiangsu Huayi Technology Co., Ltd. (Huayi) Shines Bright at the 2023 WMIC and EANM Annual Conference....